Ambeed.cn

首页 / 抑制剂/激动剂 / 神经信号通路 / MAO / Minaprine dihydrochloride

米那卜林二盐酸盐 /Minaprine dihydrochloride {[allProObj[0].p_purity_real_show]}

货号:A458274

Minaprine dihydrochloride是一种可逆的单胺氧化酶A(MAO-A)抑制剂,亦可轻微抑制乙酰胆碱酯酶,并作为抗抑郁药治疗抑郁症。

Minaprine dihydrochloride 化学结构 CAS号:25953-17-7
Minaprine dihydrochloride 化学结构
CAS号:25953-17-7
Minaprine dihydrochloride 3D分子结构
CAS号:25953-17-7
Minaprine dihydrochloride 化学结构 CAS号:25953-17-7
Minaprine dihydrochloride 3D分子结构 CAS号:25953-17-7
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Minaprine dihydrochloride 纯度/质量文件 产品仅供科研

货号:A458274 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

JMC, 2024. Ambeed. [ A919389 , A918471 , A995972 ]
Anal. Chem., 2024, 96(50): 19947-19954. Ambeed. [ A261947 , A1165388 ]
ACS Biomater. Sci. Eng., 2024. Ambeed. [ A220462 ]
ACS Biomater. Sci. Eng., 2024. Ambeed. [ A165235 , A110205 ]
Pharmaceutics, 2024, 16(12): 1546. Ambeed. [ A272538 , A187261 , A691302 , A506702 ]
更多 >
产品名称 MAO MAO-A MAO-B 其他靶点 纯度
Sennoside A ++

MAO, IC50: 17 μM

98%+
Glycyrrhizic acid ++++

MAO, IC50: 0.16 μM

80% HPLC
Rasagiline ++++

MAO-A, IC50: 412 nM

++++

MAO-B, IC50: 4.43 nM

97%
Isatin ++

MAO, IC50: 15 μM

+

MAO-A, IC50: 58 μM

++

MAO-B, IC50: 14 μM

98%
Paeonol +

MAO-A, IC50: 54.6 μM

+

MAO-B, IC50: 42.5 μM

98%
Tranylcypromine hydrochloride +++

MAO-A, IC50: 11.5 μM

+++

MAO-B, IC50: 7 μM

97%
Moclobemide +++

MAO-A (5-HT), IC50: 6.1 μM

99%+
Pargyline HCl ++

MAO-A, Ki: 13 μM

+++

MAO-B, Ki: 0.5 μM

99%+
Safinamide ++++

MAO-B, IC50: 98 nM

98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Minaprine dihydrochloride 生物活性

描述 Minaprine dihydrochloride is a reversible inhibitor of MAO-A, also weakly inhibits acetylcholinesterase and is an antidepressant for treatment of depression.

Minaprine dihydrochloride 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00940823 - Completed - -
NCT03499964 Urethral Stricture Not Applicable Recruiting November 2024 United States, Arkansas ... 展开 >> Arkansas Urology Recruiting Little Rock, Arkansas, United States, 72211 Contact: Katie O'Brien          Principal Investigator: Richard D'Anna, MD          Sub-Investigator: Keith Mooney, MD          Sub-Investigator: Edwin Diaz, MD          Sub-Investigator: Jeffrey Marotte, MD          Sub-Investigator: Megan Thomas, APRN          United States, Colorado Urology Associates, P.C. Recruiting Englewood, Colorado, United States, 80113 Contact: Lenden Neeper          Contact: Michelle Lexin          Principal Investigator: Barrett Cowan, MD          United States, Florida Advanced Urology Institute Recruiting Daytona Beach, Florida, United States, 32114 Contact: Jonelle Horsley          Principal Investigator: Jeffrey Dann, MD          United States, Maryland Chesapeake Urology Recruiting Hanover, Maryland, United States, 21076 Contact: Wendy Paxton          Principal Investigator: Kaiser Robertson, MD          Sub-Investigator: Robert Goldfarb, MD          Chesapeake Urology Research Recruiting Towson, Maryland, United States, 21204 Contact: Jacqueline Burmer          Principal Investigator: Richard Levin, MD          Sub-Investigator: Ronald Tutrone, MD          United States, Minnesota University of Minnesota Department of Urology Not yet recruiting Minneapolis, Minnesota, United States, 55445 Contact: Bethany Marlette          Principal Investigator: Sean Elliott, MD          United States, New Jersey Delaware Valley Urology Recruiting Voorhees, New Jersey, United States, 08043 Contact: Brianna Florentine          Principal Investigator: David Sussman, DO          United States, New York Western New York Urology Associates Recruiting Cheektowaga, New York, United States, 14225 Contact: Margaret Scott          Contact: Thomasina Smith          Principal Investigator: Kent Chevli, MD          Sub-Investigator: Peter Walter, MD          Columbia University Medical Center/New York-Presbyterian Hospital Not yet recruiting New York, New York, United States, 10032 Contact: Debduth Pijush          Principal Investigator: Steven Brandes, MD          Iris Cantor Men's Health Center Recruiting New York, New York, United States, 10065 Contact: Dominique Thomas          Principal Investigator: Alexis Te, MD          United States, Oregon Oregon Urology Institute Recruiting Springfield, Oregon, United States, 97477 Contact: Danna Cardenas          Principal Investigator: David DiMarco, MD          Sub-Investigator: Brian Mehlaff, MD          United States, South Carolina Carolina Urology Partners Recruiting West Columbia, South Carolina, United States, 29169 Contact: Pam Tims          Contact: Kristin Kennedy          Principal Investigator: Brian Willard, MD          Sub-Investigator: David Lamb, MD          Sub-Investigator: Keith Brightbill, MD          Sub-Investigator: Griffin Morrisson, MD          United States, Texas Urology San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Jeannette Cruz          Principal Investigator: Christopher Cantrill, MD          Sub-Investigator: Daniel Saltzstein, MD          Sub-Investigator: Clayton Hudnall, MD          Sub-Investigator: Davie Talley, MD          United States, Virginia Urology of Virginia Recruiting Virginia Beach, Virginia, United States, 23462 Contact: Daniel Bekong          Principal Investigator: Ramon Virasoro, MD          Sub-Investigator: Jessica DeLong, MD          Sub-Investigator: Jeremy Tonkin, MD          Sub-Investigator: Kurt McCammon, MD          United States, Washington University of Washington Harborview Medical Center Recruiting Seattle, Washington, United States, 98104 Contact: Michael Donahue          Principal Investigator: Judith Hagedorn, MD          Sub-Investigator: Neils Johnsen, MD 收起 <<
NCT00852852 Cancer Not Applicable Completed - United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Washington University of Washington Medical Center Seattle, Washington, United States, 98115 收起 <<

Minaprine dihydrochloride 参考文献

[1]Contreras JM, Rival YM, et al. Aminopyridazines as acetylcholinesterase inhibitors. J Med Chem. 1999 Feb 25;42(4):730-41.

Minaprine dihydrochloride 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.69mL

0.54mL

0.27mL

13.47mL

2.69mL

1.35mL

26.93mL

5.39mL

2.69mL

Minaprine dihydrochloride 技术信息

CAS号25953-17-7
分子式C17H24Cl2N4O
分子量 371.305
别名
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Inert atmosphere,Room Temperature

溶解方案

DMSO: 105 mg/mL(282.79 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 100 mg/mL(269.32 mM),配合低频超声助溶

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案一
方案二
方案三
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案一
动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。